DC48790 |
Lenalidomide-C5-NH2 TFA |
Lenalidomide-C5-NH2 is the Lenalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Lenalidomide-C5-NH2 can be connected to the ligand for protein by a linker to form PROTACs, such as MDM2 PROTAC degrader. |
|
DC50219 |
NJH-2-030 |
NJH-2-030 can be used as a covalent recruiter for FEM1B in targeted protein degradation applications. |
|
DC50053 |
E3 Ligase Ligand-Linker Conjugates 20
Featured
|
Thalidomide-O-amido-C8-NH2 (Cereblon Ligand-Linker Conjugates 2), a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs. |
|
DC50055 |
Thalidomide-NH-C6-NH2
Featured
|
Thalidomide-NH-C6-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. |
|
DC50056 |
Thalidomide-PEG2-C2-NH2
Featured
|
Thalidomide-PEG2-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology. |
|
DC50057 |
E3 ligase Ligand-Linker Conjugates 30
Featured
|
E3 ligase Ligand-Linker Conjugates 30 incorporates a cereblon (CRBN) ligand for the E3 ubiquitin ligase, and a PROTAC linker. E3 ligase Ligand-Linker Conjugates 30 can be used to design PROTAC MDM2 degrader[1]. |
|
DC50058 |
VH032-C3-NH2((S,R,S)-AHPC-C3-NH2)
Featured
|
(S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the VH032 based VHL ligand and a linker used in PROTAC technology. (S,R,S)-AHPC-C3-NH2 can be used in the synthesis of a series of PROTACs, such as UNC6852. UNC6852 is an EED-targeted bivalent chemical degrader[1]. |
|
DC50059 |
(S,R,S)-AHPC-C4-NH2
Featured
|
(S,R,S)-AHPC-C4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and a linker used for EED-Targeted PROTAC[1].
|
|
DC50060 |
(S,R,S)-AHPC-C2-NH2 dihydrochloride
Featured
|
(S,R,S)-AHPC-C2-NH2 dihydrochloride incorporates a VHL ligand for the E3 ubiquitin ligase, and a PROTAC linker. (S,R,S)-AHPC-OH can be used in the synthesis of a series of PROTACs[1]. |
|
DC50062 |
Thalidomide-NH-PEG1-C2-NH2
Featured
|
Thalidomide-NH-PEG1-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. |
|
DC50063 |
(S,R,S)-AHPC-C6-NH2
Featured
|
PROTAC building block. |
|
DC50064 |
(S,R,S)-AHPC-C10-NH2 (VH032-C10-NH2)
Featured
|
(S,R,S)-AHPC-C10-NH2 (VH032-C10-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and a linker used for BET-Targeted PROTAC. |
|
DC50065 |
(S,R,S)-AHPC-CO-CI-Br
Featured
|
(S,R,S)-AHPC-CO-CI-Br is a novel protac building block, |
|
DC50066 |
(S,R,S)-AHPC-acetamido-O-C2-amine HCI
Featured
|
(S,R,S)-AHPC-acetamido-O-C2-amine HCI is a novel PROTAC building block. |
|
DC50068 |
(S,R,S)-AHPC-Me-C10-NH2
Featured
|
(S,R,S)-AHPC-Me-C10-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the a VHL ligand and a linker. (S,R,S)-AHPC-Me-C10-NH2 can be used in PROTAC MS432 |
|
DC50069 |
(S,R,S)-AHPC-PEG4-NH2(E3 ligase Ligand-Linker Conjugates 7)
Featured
|
(S,R,S)-AHPC-PEG4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 4-unit PEG linker used in PROTAC technology. |
|
DC50070 |
(S,R,S)-AHPC-PEG2-NH2 (E3 ligase Ligand-Linker Conjugates 6 Free Base)
Featured
|
(S,R,S)-AHPC-PEG2-NH2 (VH032-PEG2-NH2) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs. |
|
DC50071 |
(S,R,S)-AHPC-PEG2-NH2 hydrochloride E3 ligase Ligand-Linker Conjugates 6)
Featured
|
(S,R,S)-AHPC-PEG2-NH2 hydrochloride (VH032-PEG2-NH2 hydrochloride) is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 2-unit PEG linker used in the synthesis of PROTACs. |
|
DC50072 |
(S,R,S)-AHPC-PEG3-NH2 (E3 ligase Ligand-Linker Conjugates 5)
Featured
|
(S,R,S)-AHPC-PEG3-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 3-unit PEG linker used in PROTAC technology. |
|
DC50073 |
(S,R,S)-AHPC-PEG3-NH2 hydrochloride(E3 ligase Ligand-Linker Conjugates 5)
Featured
|
(S,R,S)-AHPC-PEG3-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and 3-unit PEG linker used in PROTAC technology. |
|
DC50074 |
(S,R,S)-AHPC-Me-C1-NH2
Featured
|
(S,R,S)-AHPC-Me-C1-NH2 is a novel PROTAC Building block. |
|
DC50075 |
(S,R,S)-AHPC-Me-C2-NH2
Featured
|
(S,R,S)-AHPC-Me-C2-NH2 is a novel PROTAC building block. |
|
DC50076 |
(S,R,S)-AHPC-Me-C3-NH2
Featured
|
(S,R,S)-AHPC-Me-C3-NH2 is a novel PROTAC building block. |
|
DC50077 |
(S,R,S)-AHPC-Me-C4-NH2
Featured
|
(S,R,S)-AHPC-Me-C4-NH2 is a novel PROTACA building block. |
|
DC50078 |
(S,R,S)-AHPC-Me-C8-NH2
Featured
|
(S,R,S)-AHPC-Me-C8-NH2 is a novel PROTAC building block. |
|
DC50079 |
Thalidomide-O-amido-C5-NH2
Featured
|
Thalidomide-O-amido-C5-NH2 is a novel PROTAC building block. |
|
DC71952 |
Pomalidomide-C12-NH2 hydrochloride |
Pomalidomide-C12-NH2 hydrochloride is the E3 ligase ligand-linker conjugate of PROTAC KRAS G12C degrader-1. PROTAC KRAS G12C degrader-1 is a Cereblon-based KRASG12C degrader. |
|